Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma

BACKGROUND: Proficient mismatch repair (pMMR) colorectal adenocarcinoma (CRAC) metastasizes to a greater extent than MMR-deficient CRAC. Prognostic biomarkers are preferred in clinical practice. However, traditional biomarkers screened directly from sequencing are often not robust and thus cannot be...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yixi, Li, Dehua, Chen, Yang, Lu, Yongping, Zhou, Fangbin, Li, Chunhong, Zeng, Zhipeng, Cai, Wanxia, Lin, Liewen, Li, Qiang, Ye, Mingjun, Dong, Jingjing, Yin, Lianghong, Tang, Donge, Zhang, Gong, Dai, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529276/
https://www.ncbi.nlm.nih.gov/pubmed/34692502
http://dx.doi.org/10.3389/fonc.2021.727752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529276/
https://www.ncbi.nlm.nih.gov/pubmed/34692502
http://dx.doi.org/10.3389/fonc.2021.727752

Ejemplares similares